Buy Leucowin Leucovorin Calcium IP

Leucowin (Leucovorin Calcium IP) 50mg/5ml vials provide folinic acid rescue therapy for chemotherapy patients. Used to reduce toxic effects of methotrexate, this sterile injectable supports healthy cell function during cancer treatment. Reliable folate rescue solution for oncology protocols.

Strength

50mg/5ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Beta Drugs Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Leucovorin Calcium IP is primarily used as a rescue agent following high-dose methotrexate chemotherapy to protect normal cells from toxicity. It also enhances the effects of 5-fluorouracil in colorectal cancer treatment by stabilizing the drug-target interaction. This folate analog supports DNA synthesis and repair in rapidly dividing cells.

Side Effects

Leucovorin Calcium IP helps restore folate levels in the body, supporting cellular function during chemotherapy. Patients may experience improved tolerance to cancer treatments when this rescue agent is administered as directed. The medication works by bypassing blocked metabolic pathways caused by folate antagonists.

Precautions & Warnings

Store Leucowin vials at controlled room temperature away from moisture and heat. Protect from light during storage and administration. Use only as prescribed by a healthcare professional for chemotherapy protocols. Discard any unused portion according to medical waste guidelines.

Avoid Interactions

Leucovorin may interact with certain chemotherapy drugs, antibiotics, and anticonvulsants affecting their metabolism. Combining with folic acid supplements may alter therapeutic effects. Alcohol consumption should be avoided during treatment. Always inform your healthcare provider about all medications being taken.

References

Frequently Asked Questions

It is used as a rescue agent after high-dose methotrexate chemotherapy and to enhance 5-fluorouracil therapy in colorectal cancer.

Leucowin is administered as an intravenous injection by healthcare professionals following chemotherapy protocols.

It may interact with certain drugs; always consult your healthcare provider before combining therapies.

Possible effects include nausea, vomiting, or allergic reactions; report any adverse effects to your doctor.

Consult your healthcare provider as folate supplementation may be required during pregnancy.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.